Literature DB >> 16459110

Neuropsychological morbidity linked to childhood sleep-disordered breathing.

Ann C Halbower1, E Mark Mahone.   

Abstract

Understanding the long-term neuropsychological consequences of sleep disorders in children poses a significant challenge to researchers. Since children are in a state of rapidly changing cognition and neurobehavioral function, impacts on development may have profound consequences. Recent studies now demonstrate that mild sleep apnea and snoring, once considered within the spectrum of normal sleep patterns, are associated with deficits of neuropsychological function. Preliminary data suggest that some of these cognitive deficits may be reversible following treatment of mild sleep apnea in children; however, factors such as age at treatment, duration of sleep disordered breathing, pre-morbid intellectual level, socioeconomic status, or the effectiveness of treatment may adversely affect long-term outcome. Furthermore, it is imperative that researchers determine whether the developing brain exhibits critical periods of plasticity during which episodes of sleep-disordered breathing might cause long-term or permanent neuropsychological effects.

Entities:  

Mesh:

Year:  2006        PMID: 16459110     DOI: 10.1016/j.smrv.2005.10.002

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  18 in total

1.  The association between sleep disordered breathing, academic grades, and cognitive and behavioral functioning among overweight subjects during middle to late childhood.

Authors:  Dean W Beebe; M Douglas Ris; Megan E Kramer; Elizabeth Long; Raouf Amin
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

2.  Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis.

Authors:  Teresa M Ward; Dean W Beebe; Maida Lynn Chen; Carol A Landis; Sarah Ringold; Ken Pike; Carol A Wallace
Journal:  J Rheumatol       Date:  2017-01-15       Impact factor: 4.666

Review 3.  Sleep in children with autism spectrum disorders.

Authors:  Kyle P Johnson; Beth A Malow
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

4.  Respiratory and polysomnographic values in 3- to 5-year-old normal children at higher altitude.

Authors:  Casey J Burg; Hawley E Montgomery-Downs; Pamela Mettler; David Gozal; Ann C Halbower
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

5.  Polysomnographic Markers in Children With Cystic Fibrosis Lung Disease.

Authors:  Shruti M Paranjape; Brian M McGinley; Andrew T Braun; Hartmut Schneider
Journal:  Pediatrics       Date:  2015-10-19       Impact factor: 7.124

6.  Sleep of children living in institutional care facilities.

Authors:  Maha K Abou-Khadra
Journal:  Sleep Breath       Date:  2011-09-14       Impact factor: 2.816

Review 7.  Executive summary of respiratory indications for polysomnography in children: an evidence-based review.

Authors:  Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

8.  High-Flow, Heated, Humidified Air Via Nasal Cannula Treats CPAP-Intolerant Children With Obstructive Sleep Apnea.

Authors:  Stephen Hawkins; Stephanie Huston; Kristen Campbell; Ann Halbower
Journal:  J Clin Sleep Med       Date:  2017-08-15       Impact factor: 4.062

9.  Cognitive Effects of Adenotonsillectomy for Obstructive Sleep Apnea.

Authors:  H Gerry Taylor; Susan R Bowen; Dean W Beebe; Elise Hodges; Raouf Amin; Raanan Arens; Ronald D Chervin; Susan L Garetz; Eliot S Katz; Reneé H Moore; Knashawn H Morales; Hiren Muzumdar; Shalini Paruthi; Carol L Rosen; Anjali Sadhwani; Nina Hattiangadi Thomas; Janice Ware; Carole L Marcus; Susan S Ellenberg; Susan Redline; Bruno Giordani
Journal:  Pediatrics       Date:  2016-08       Impact factor: 7.124

10.  Sleep in children with autism spectrum disorders.

Authors:  Kyle P Johnson; Beth A Malow
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.